Mazur, N. I., Terstappen, J., Baral, R., Bardají, A., Beutels, P., Buchholz, U. J., Cohen, C., Crowe, J. E., Cutland, C. L., Eckert, L., Feikin, D., Fitzpatrick, T., Fong, Y., Graham, B. S., Heikkinen, T., Higgins, D., Hirve, S., Klugman, K. P., Kragten-Tabatabaie, L., Lemey, P., Libster, R., Löwensteyn, Y., Mejias, A., Munoz, F. M., Munywoki, P. K., Mwananyanda, L., Nair, H., Nunes, M. C., Ramilo, O., Richmond, P., Ruckwardt, T. J., Sande, C., Srikantiah, P., Thacker, N., Waldstein, K. A., Weinberger, D., Wildenbeest, J., Wiseman, D., Zar, H. J., Zambon, M., & Bont, L. (2023). respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet infectious diseases, 23(1), e2–e21. http://access.bl.uk/ark:/81055/vdc_100173088937.0x00000f